Clinical trial

Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence

NCT00215579

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-04-01

PhasePHASE4

Study timeline

Study start (unknown)2004-04-01Date precision: month

Registry last updated2014-09-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Interventions

Depot Risperidone Microsphere (Consta)DRUG

Sponsors & collaborators

Duke Universitylead sponsor

Janssen, LPcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00215579 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.